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INTRODUCTION
Fetal Growth Restriction (FGR) is still a major
health burden as it is associated with increased
neonatal morbidity and mortality.1 It occurs in 10
- 15% of pregnant women and is usually diagnosed
during pregnancy, while some fetuses were diag-
nosed after birth.2 FGR incidence varies from coun-
try to country. In developing countries, its inci-
dence is 25% higher compared to developed coun-
tries, which is amounted to 4-8%, where the
highest prevalence is in Asia (75%), especially in
Southeast Asia and followed by Africa (20%),
whereas in Latin America is 5%.2,3 The prevalence
of FGR in 4 fetomaternal centers in Indonesia in
2004-2005 was 4.4 %, with the highest prevalence
(6.44%) were reported in dr. Sardjito Central
General Hospital Yogyakarta. The perinatal morta-
lity rate were 7-8 times higher than normal babies.
Approximately 26% or more stillbirth events were
associated with FGR.4
FGR is defined as a condition where the fetal
weight is below 10 percentile of gestational age or
less than 2 standard deviations below the mean of
gestational age.3 It can also be diagnosed when
abdominal circumference is less than or equal
to 5 percentile or femur length (FL) / abdominal
circumference (AC) >24.5
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Objective: To determine the role of HLA-C and NK cell expressions
in fetal growth restriction (FGR).
Methods: A cross sectional study design was used. This study was
conducted at the Obstetrics and Gynecology Department of Dr.
Moewardi General Hospital, Surakarta, its affiliated hospitals, and at
the Pathological Anatomy Laboratory of the Faculty of Medicine,
University of Sebelas Maret Surakarta. A total of 40 samples were
included in this study. The samples consisted of 20 normal preg-
nancies and 20 pregnancies with FGR. HLA-C expression in the
trophoblast and NK cells in decidua of the subjects who met the
inclusion and exclusion criteria were examined using immuno-
histochemical method and statistical analysis with T test.
Results: The mean expression of HLA-C in the trophoblast in the
pregnant group with FGR was 9.021.30, normal pregnancy was
7.960.97, p=0.01 (p<0.05). The mean expression of NK cells in
decidua of pregnancy with FGR was 10.592.11, normal pregnancy
was 0.918.18, with p=0.00 (p<0.05).
Conclusion: The expressions of HLA-C in trophoblast and NK cells
in decidua of pregnancy with FGR were higher compared with
those of normal pregnancy.
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Abstrak
Tujuan: Untuk menentukan peran ekspresi HLA-C dan sel NK
pada pertumbuhan janin terhambat (PJT).
Metode: Penelitian ini menggunakan desain studi potong lintang.
Penelitian dilakukan di bagian Obstetri dan Ginekologi RS Dr.Moewardi Surakarta dan rumah sakit-rumah sakit jejaringnya, dan
Laboratorium Patologi Anatomi Fakultas Kedokteran Universitas
Sebelas Maret Surakarta. Besar sampel adalah 40, terdiri dari 20kehamilan normal dan 20 kehamilan dengan PJT. Subjek yang
memenuhi kriteria inklusi dan eksklusi dilakukan pemeriksaanekspresi HLA-C di trofoblas dan sel NK di desidua dengan metode
imunohistokimia dan dilakukan analisis statistik dengan uji t.
Hasil: Rerata ekspresi HLA-C di trofoblas pada kelompok hamil
dengan PJT 9,021,30, kehamilan normal 7,960,97, dengan p=0,01
(p<0,05). Rerata ekspresi sel NK di desidua pada hamil dengan PJT10,592,11, kehamilan normal 8,180,91, dengan p=0,00 (p<0,05).
Kesimpulan: Ekspresi HLA-C di trofoblas dan Sel NK di desidua hamil
dengan PJT lebih tinggi bila dibandingkan dengan kehamilan normal.
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The identification of FGR is important. It is
essential to know the risk factors in FGR, which
include maternal cause and fetal cause, and pla-
cental factor. Intrauterine growth determines the
perinatal, postnatal, and adulthood development.
FGR is often associated with an increased risk that
develops to metabolic diseases in the adulthood
including hypertension, diabetes mellitus, obesity,
dyslipidemia, and metabolic syndrome.2
The success of pregnancy process depends on
many factors, one of which is immune adaptation
of the pregnancy where fetal maternal immune
tolerance is very important. Fetus as semi-
allogeneic can cause immune maladaptation that
will produce poor perinatal outcomes such as FGR
to mother.6
The cause of FGR among other is the disturbance
of uteroplacental blood flow that is now often
associated with a condition where atolerance in-
terruption on maternal immune system occurs
and results in disruption of trophoblast invasion
into decidua during placentation process, in the
form of inadequate invasion that results in
disruption invasion of placenta which will lead to
poor uteroplacental perfusion resulting in the
occurrence of pregnancy complications such as
FGR.7 Plasma cells’ infiltration in the decidua will
cause decidua vasculopathy, where macrophage
infiltration participate in extravillus interstitial
trophoblast cell death by apoptosis which causes
leukocytes to surround or attack the placental villi.
This portrait was found in FGR placenta.8
Histocompatibility antigen is a gene that
encodes a protein that affects the tissue transplant
compatibility. The antigen is divided into two
systems, namely minor histocompatibility antigen
and major histocompatibility complex (MHC). MHC
gene is known as Human Leucocyte Antigen (HLA)
in humans. MHC is divided into regions that encode
three different classes of HLA molecules, namely
HLA-I, II, and III which are different structurally
and functionally. Classic HLA molecule is encoded
by three loci, namely HLA-A, HLA-B, and HLA-C
which are very polymorphic.9
The expression of class I non-classic HLA
molecules is limited to specific certain type of cell,
but is generally expressed in placental trophoblast
cells where HLA-G has the strongest expression
while HLA-E has medium expression. Both class II
HLA molecules and class I classic HLA molecules
are not expressed in the placenta, with the excep-
tion of the existence of a weak expression of classic
HLA-C molecule. This makes the function of non-
classical HLA molecules and classical HLA-C mole-
cules interesting, in line with mother’s acceptance
to semi-allogeneic fetus during pregnancy. High
expression of HLA-G and HLA-E will bind to
Natural Killer cells (NK cell) receptor inhibitor that
will causes prevention on NK cells to secrete pro-
inflammatory cytokines. Whereas, if high levels of
HLA-C inhibit NK cell function that causes the
secretion of angiogenic and mitogenic endothelial
ineffective, placentation and vascular remodeling
will be interfered.10
Human Leucocyte Antigen-C molecule is a
heterotrimer composed of glycoproteinsized 45
kD, a 12 kD 2m invariant, and a binding peptide.
Cell surface of proteins is highly polymorphic, with
1016 known all that encode 750 proteins. HLA-C
has expression level on low cell surface (i.e. 10%
of the HLA-A or B). The main role of the HLA-C is
a ligand for KIR. NK cell receptor for HLA-C is a
member of a multigene Killer Inhibitor Receptor
(KIR) family. Locus of HLA-C is dimorphic and both
groups of HLA-C interact with different KIR. NK cell
receptors tend to aim to HLA-C introduction in the
uterus. All women express KIR in both HLA-C all
groups, and because HLA-C is polymorphic, the
interaction between non-self paternal fetus HLA-C
and maternal decidua NK cell KIR occurs during
pregnancy progresses. Every pregnancy will
involve different combinations of HLA-C paternal
fetus and maternal KIR, therefore it is possible that
some combinations are less than optimal for
implantation and ultimately lead to failure of
pregnancy. It becomes the basis of pathogenesis of
important diseases in pregnancy, such as the fetal
growth retardation. Trophoblast cells that invade
the maternal uterine tissue express HLA-C at high
levels in a stable conformation of 2. HLA-C with
trophoblast cells perform direct contact with
maternal NK cells that express KIR at the site
where placentation take place.6,7
Decidua NK cells affect trophoblast ability to in-
vade and alter spiral arteries and regulates blood
flow into the intervillous chamber by regulating
the transformation of trophoblast arteries. NK cells
are a type of lymphocyte with a large size that con-
tains many granules in the cytoplasm (LGL). The
cells function to kill cells, produce cytokines, and
produce growth factors such as VEGF and PLGF.6
Decidua NK cells express specific KIR receptors
that bind HLA-C. The binding of HLA-C on KIR
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inhibitory signals as well as activating signals of NK
cells, depending on the type of the KIR. Decidua NK
cells express specific KIR that binds HLA-C on a
higher level than peripheral NK cells. Some ligands
of the receptor are class I HLA molecules and these
interactions can activate KIR/KIR2DS1 or inhibit
KIR/KIR2DL1.11,12 NK cells express receptors with
different complement that have a chain either
activating or inhibiting signal. CD 56 Brigth uterine
NK cells express diverse receptors including
immunoglobulin receptor killer which is known to
recognize HLA-C.6
All HLA-C all types can be grouped into two
main KIR epitopes, C1 and C2. C1 group is ligand for
receptor of KIR2DS2 NK cell activator that is asso-
ciated with increased birth weight, and C2 group is
ligands for receptor of KIR2DL1 NK cell inhibitor
that is related with pregnancy disorders as abnor-
mal placentation.11 Fetus vascular supply control
relies on the interaction between maternal KIR on
decidua NK cells and paternal HLA-C expressed
by trophoblast. HLA-C has a relationship with the
development of fetal growth retardation. The
combination of maternal decidua NK cells, namely
maternal KIR with HLA-C2 fetal genotype (HLA-C
receptor inhibitor), can increase the risk of fetal
growth retardation. When maternal AA genotype
coincided with HLA-C2 genotype heterozygous or
homozygous fetus, decidua NK cells expressing KIR
genotype AA will be inhibited, because haplotype
A has KIR receptor inhibitor (KIR2DLI1). This
receptor can inhibit cytokines secretion from NK
cells that are believed to facilitate the normal
trophoblast invasion. If NK cells are not activated,
these cells potentially cause inadequate tropho-
blast invasion, which resulted in the failure of
placentation and lead to fetal growth retardation.7
C1 does not cause the same inhibition on KIR
haplotype A that is caused by weak binding of
HLA-C1 on the corresponding inhibitor KIR2DL2/3
compared to HLA-C2 binding on KIR2DL1. There-
fore, C1 does not inhibit NK cell on the same level
with the C2. When C2 coincided with B KIR haplo-
type, then activated KIR haplotypes will neutralize
the inhibition signals.11
This study is aimed to analyze the expression of
HLA-C and NK cells in FGR, and is expected to be
a predictor of FGR occurrence so as to prepare FGR
therapy.
METHODS
A cross sectional study design was used. This study
was conducted at the Obstetrics and Gynecology
department of Dr. Moewardi General Hospital
Surakarta and its affiliated hospitals. HLA-C and NK
cells expression was assessed using immunohisto-
chemistry method performed in the Pathological
Anatomy Laboratory, Faculty of Medicine, Univer-
sitas Sebelas Maret Surakarta.
The study was conducted on pregnant women
with FGR (fetal weight  10th percentile or fetal
abdominal circumference  5 percentile or the ratio
of femur length/abdominal circum ferent (FL/AC)
>24) on ultrasound examination and normal preg-
nant women to analyze HLA-C expression intro-
phoblast and NK cells in the decidua. The sample
size is determined based on Multi formula that for
each group contains 20 people.13 The inclusion
criteria were mothers aged 20 - 35 years, 34 - 40
weeks of gestational age inpregnancy with FGR
cases, and 37 - 40 weeks of gestational age in
normal pregnancy, single fetus, remind alive, and
have willingness to participate in the research.
Exclusion criteria were mothers with diabetes
mellitus, kidney disease, heart disease, liver
disease, chronic hypertension, infectious disease
and smoking, fetal death in utero, fetus with major
congenital abnormalities. Both groups underwent
examination on the expression of HLA-C and NK
cells in extravillous trophoblast which expressed
HLA-C and decidua NK cells accumulated in the
surrounding area.
Immunohistochemistry Examination
Tissue slide preparation was done in several steps,
and was initiated by taking cotyledon tissue sample
from the placenta (trophoblast). Trophoblast was
fixed using buffered formalin solution for 8 hours
or up to 48 hours, and then inserted into tissue
cassette and soaked in 50%, 70%, 80%, and 95%
alcohol solution, followed by cleaning using xylol 3
times for 60 minutes or each prepration. During
the embedding process, each preparation was
immersed in liquid paraffin with a melting point
of 58°C at a temperature of 45°C in an incubator
for 18 hours, then paraffin blocks were made
and affixed to the holder and were cut 4 - 5
microns thick with a rotary microtome. The tissues
were laid on poly L-lysine slides. Glass objects
resulted from paraffin blocks were immersed in
xylol 4 times for 5 minutes each. Next, rehydration
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was applied using series alcohol (absolute, 95
70%) and then rinsed with the distilled water
(H2O) for 5 minutes. The slides were washed with
PBS pH 7.4, twice for 5 minutes and was dripped
with endogenous peroxidase methanol H2O2 0.3%
for 15 minutes then rinsed with running water for
5 minutes and rinsed again with distilled water for
5 minutes. Next repeated rinse was applied using
PBS 2 x 5 minutes, and followed with retrieval
using Tris EDTA pH buffer 9 in microwave or
declocing chamber and then washed with PBS 2 x
5 minutes and dripped with snifer background
when it was already cool. It must be drained before
dripping with prepared monoclonal antibodies
HLA-C and incubated at 4°C for 18 hours. Sub-
sequently, it was washed again with PBS 2 x 5
minutes, and afterwards, dripped with secondary
antibody (universal trekkielibk) for 15 minutes
and washed with PBS 2 x 5 minutes, then followed
with dripping streptavidin for 10 minutes, washed
with PBS 2 x 5 minutes after administration of
peroxidase substrate diethyl amino benzene for 10
minutes. Another wash was given with water for 5
minutes, and then dripped with hematoxylin for 2
minutes and rinsed with running water for 5
minutes and mounted using entelan and covered
with glass cover. Finally, light microscope was used
to observe. The expression of HLA-C and NK cells
were shown with a bluish tint for weak positive,
golden yellow for moderate positive, and brown for
strong positive on the trophoblast. Observations
were made as much as 9 field of view. Trophoblast
cell number was calculated based on the expres-
sion intensity, and the percentage was made from
whole number of cells. The percentage obtained
was converted into numbers and calculated
according to histological score formula. Scoring of
HLA-C and NK cell image was conveyed as
Histology Score (HS) which was done based on the
formula: HS = (PK x IK) + (PS x IS) + (PL x IL) +
(PN x IN)
Formula explanation:
P = Percentage N = Negative L = Weak
K = Strong   I = Intensity  S = Medium
The HS of HLA-C and NK cells was classified as
follows. The percentage/percentage of number of
cells: 0-25% = negative; 26 - 50% = weak positive;
51-75% = moderate positive; 76-100% = strong
positive; for the qualitive meaning: 0.00 to 3.75 =
negative; 3.76 to 7.50 = weak positive; 7.51 - 11.25
= moderate positive; 11.26 to 15.00 = strong
positive.14,15
Data were analyzed using T test. Reagent used
for the expression of HLA-C was HLA-C (H-5)
antibody reagent sc-166 134 Santa Cruz Biotech-
nology, Inc. Meanwhile, the reagent used for the
expression of NK cell was rabbit polyclonal anti-
body Anti KIR2DL1 bs-2419R BIOSs, Inc., and KIR
was used to see the expression of NK cell receptors.
Observation on intensity of the color was done by
using Olympus CX-21 series light microscope, 400x
magnification on 9 field of view. The number of
HLA-C and NK cells on trophoblast was calculated
based on the intensity of the reddish-brown color
and the percentage. The higher the histological
score, the stronger the expression.15
Ethical Clearance
Ethical Clearance was obtained from EIK Health
Research Commission Dr. Moewardi General
Hospital - Faculty of Medicine, University of
Sebelas Maret Surakarta Number: 461/VI/HREC/
2015 dated June 25, 2015.
RESULTS
Table 1. Characteristics of Research Subjects
Variable N Min Max Mean SD
Maternal age (years) 40 20.00 35.00 29.50 4.06
Gestational age (weeks) 40 37.00 40.00 38.87 0.88
Birth weight (grams) 40 1800.00 3100.00 2421.25 504.32
Body mass index 40 17.31 24.15 19.89 1.83
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Characteristics of the research subjects showed
the average age of pregnant women was 29.50
4.06 years, gestational age was 38.870.88
weeks, birth weight was 2421.25504.32 g, BMI
was 19.891.83.
The mean expression of HLA-C in pregnancies
with FGR was higher (9.021.30), compared with
normal pregnancy (7.960.97), p=12.01 (<0.05).
Average NK cells (KIRDL1) in pregnancy with FGR
were higher (10.592.11), compared to normal
pregnancies (8.180.91) with p=0.00 (<0.05).
HLA-C expressed in trophoblast in brown color
on the core which extends into the cytoplasm of
trophoblast extravillous. From the immunohisto-
chemical method reading, HLA-C mean score on
trophoblast tissue in FGR group was higher when
compared with normal pregnancy group. HLA-C
expression on trophoblast was assessed using
Olympus CX-21 series light microscope with a
magnification of 400 times.
The color of expressed decidual NK cells in
cytoplasm was red. The mean score of NK cell
expression on FGR group tissues was higher was
compared to the normal pregnancy group.
Expression of NK cells in the decidua by Im-
munohistochemistry method using Olympus CX-21
series light microscope with magnification of 400
times. Figure 2A: NK cell expression in normal
pregnancy. Figure 2B: NK cells expression in FGR.
NK cells positive if the color is red in the cytoplasm.
              Figure 2. NK Cell Expression in FGR and Normal Pregnancy.
Table 2. Mean Expression of HLA-C and NK Cells in Pregnancy with FGR and Normal Pregnancy
Variable Pregnancy with FGR(N=20) Normal Pregnancy(N=20) p
HLA-C (% cells / field of view) 9.021.30 7.960.97 0.01*
NK cells (% cells / field of view) 10.592.11 8.180.91 0.00*
Description *p significant <0.05
              Figure 1. HLA-C Expression on FGR and Normal Pregnancy.
Indones J
146  Sulistyowati et al Obstet Gynecol
DISCUSSION
The success of pregnancy depends on many
factors, one of which is immune adaptation of
the pregnancy in which fetal maternal immune
tolerance is very important. Immune maladapta-
tion can cause miscarriage, preeclampsia, fetal
growth restriction, preterm, or gestational diabetes
mellitus associated with excessive activation of
immunology and disregulation.6 Fetus is the result
of an interaction of placenta with maternal
immune system that has direct contact with semi-
allogeneic fetus during pregnancy. A special type
of cell derived from the fetus, called trophoblast,
invades the uterus and contact directly with the
maternal immune system.10 Extravilloustropho-
blast cells produce histocompatibility polymorphic
antigen known as human leukocyte antigens-C
(HLA-C) that will interact with killer immunoglo-
bulin receptors (KIR) on maternal decidua NK cells
that is suspected to have a role in regulating
physiological functions related to placenta deve-
lopment.16 Therefore, it is said that HLA-C expres-
sion plays a role in the success of pregnancy.7
In this study, the mean of HLA-C expression in
pregnancy with fetal growth retardation was
higher (9.021.30), compared to normal pregnancy
(7.960.97), with p=0.006 (p<0.05). The mean of
NK cells (KIRDL1) expression in the group with
fetal growth retardation was higher (10.592.11)
compared to normal pregnancy (8.180.91), with
p=0.00 (<0.05).
The results were consistent with a study con-
ducted by Hviid (2006) where HLA-C expression
on cases of intrauterine growth was higher than
normal. High HLA-C would inhibit NK cell function
so that the secretion of angiogenic and mitogenic
endothelial was ineffective that would interfere
placentation and vascular remodeling. The balance
between non-classical HLA molecules and the
classical HLA-C was required for the success
of normal pregnancy.10 A study conducted by
Haumonte (2014) was also consistent with this
research that HLA-C, which is part of the MHC
Class I, was high in cases of intrauterine fetal
death, fetal growth retardation, and the highest
frequency in preeclampsia.17
HLA-C has a relationship with intrauterine
growth due to the success of pregnancy depends
on the expression of HLA-C.7 Vascular supply
control of the fetus depends on the interaction
between maternal KIR on decidua NK cells and
paternal HLA-C expressed by trophoblast. The
combination of maternal decidua NK cells, namely
maternal KIR with fetus HLA-C2 genotype (ligand
for receptor of KIR2DL1 NK cell inhibitor) can
increase the risk of fetal growth retardation. When
the AA genotype maternal concurred with geno-
type HLA-C2 heterozygous or homozygous fetus,
decidua NK cells expressing KIR genotype AA is to
be inhibited, because haplotype A KIR receptor
inhibitor (KIR2DLI1). These receptors can inhibit
the secretion of cytokines from NK cells are
believed to facilitate the normal trophoblast
invasion. If NK cells are not activated, these cells
potentially cause inadequate trophoblast invasion,
which resulted in the failure of placentation leading
to fetal growth retardation. On FGR expression of
HLA-C gene C2 is higher in trophoblast.7,11
To reinforce that HLA-C2 type with KIR2DL1 in-
hibitor as a cause of FGR which is C1 (ligands for
receptors of NK KIR2DS2 cell activator) do not
cause same inhibition on A KIR haplotype that is
caused by weak binding of HLA-C1 to the corre-
spondent inhibitor KIR2DL2/3 compared to HLA-C2
binding on KIR2DL1. Therefore, C1 cannot inhibit
NK cell on the same level with the C2. When C2
coincides with the KIR B haplotype, the activated
KIR haplotype will neutralize inhibition signals.7
Farrel (2014) found no relationship between
KIR and HLA-C which were seen in bad placenta
and demonstrated the importance of maternal-
fetal immune interactions to determine the out-
come of the pregnancy. Maternal KIR inhibition
combined with HLA-C2 fetal is associated with low
fetal weight, while the activation of fetal maternal
KIR with HLA-C2 is associated with increasing fetal
weight.18 In this study, the high expression of
KIR2DLI1, an inhibitor of maternal KIR, is associa-
ted with fetal growth restriction.
Beaman (2014) showed a little difference but
was still relevant to our study that the combina-
tion of KIR receptor activation that interacted
with HLA-C1 haplotype would produce GM-CSF
that was useful in placentation. If trophoblast
expresses HLA-C2 inhibitor that interacts with
receptors on NK cells, so that the cells are inactive
and will result in preeclampsia, FGR, and recurrent
miscarriage. A suitable combination will cause
activations of NK cells and angiogenesis during
placental growth and cause a good pregnancy,
if the combination does not proper, it brings
difficulty during pregnancy period.19
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According to a theory by Hanna (2006), the risk
of fetal growth restriction would increase if the
mother had KIR haplotype inhibitor and the fetus
had HLA-C2 gene which would lead to inhibition of
NK cell activity which is not expected to occur
during pregnancy.20
Sharkey (2008) found that KIR/HLA-C inter-
action was biologically important in regulating
placentation. KIR that binds HLA-C is expressed
more strongly in decidua NK cells than peripheral
NK cells derived from the same woman at the same
time. The strongest expression of KIR is in early
gestation (6 weeks), and it decreases slowly after
the first trimester.21
Decidual NK cells produce several chemokines
and angiogenic cytokines. It shows that NK cells
play a role by releasing its cytokines in controlling
pregnancy, besides functioning through cytotoxic
mechanism. Activated KIR may not only activate
the function of cytotoxic killer, but also activates
the production of certain cytokines that can induce
trophoblast invasion. This can explain the reason
that NK cells have activating receptors for class I
HLA molecule. Decidua NK clones that express
activated KIR2DS4 receptors secrete large amounts
of growth factors (VEGF, PLGF, IL-8 and IP-10),
when incubated with cells that have experienced
transfection with HLA-C2 group. Decidua NK cells
that express KIR2DL1 receptor inhibitor secrete
fewer growth factors when transfected with
HLA-C2.20
CONCLUSION
The expression of HLA-C and NK cells are higher
in fetal growth restriction compared to normal
pregnancy.
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